<VariationArchive RecordType="classified" VariationID="11111" VariationName="NM_000116.5(TAFAZZIN):c.605_608del (p.Glu202fs)" VariationType="Deletion" Accession="VCV000011111" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2022-03-28" MostRecentSubmission="2022-03-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="26150" VariationID="11111">
      <GeneList>
        <Gene Symbol="TAFAZZIN" FullName="tafazzin, phospholipid-lysophospholipid transacylase" GeneID="6901" HGNC_ID="HGNC:11577" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154411539" stop="154421726" display_start="154411539" display_stop="154421726" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153639876" stop="153650064" display_start="153639876" display_stop="153650064" Strand="+" />
          </Location>
          <OMIM>300394</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000116.5(TAFAZZIN):c.605_608del (p.Glu202fs)</Name>
      <CanonicalSPDI>NC_000023.11:154420050:TGAGTG:TG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq28</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154420051" stop="154420054" display_start="154420051" display_stop="154420054" variantLength="4" positionVCF="154420050" referenceAlleleVCF="CTGAG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153648390" stop="153648393" display_start="153648390" display_stop="153648393" variantLength="4" positionVCF="153648389" referenceAlleleVCF="CTGAG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>E158fs</ProteinChange>
      <ProteinChange>E188fs</ProteinChange>
      <ProteinChange>E202fs</ProteinChange>
      <ProteinChange>E206fs</ProteinChange>
      <ProteinChange>E172fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.153648392_153648395del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.153648392_153648395del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.154420053_154420056del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.154420053_154420056del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181311.4" sequenceAccession="NM_181311" sequenceVersion="4" change="c.515_518del">
            <Expression>NM_181311.4:c.515_518del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_851828.1" sequenceAccession="NP_851828" sequenceVersion="1" change="p.Glu172fs">
            <Expression>NP_851828.1:p.Glu172fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181312.4" sequenceAccession="NM_181312" sequenceVersion="4" change="c.563_566del">
            <Expression>NM_181312.4:c.563_566del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_851829.1" sequenceAccession="NP_851829" sequenceVersion="1" change="p.Glu188fs">
            <Expression>NP_851829.1:p.Glu188fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181313.4" sequenceAccession="NM_181313" sequenceVersion="4" change="c.473_476del">
            <Expression>NM_181313.4:c.473_476del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_851830.1" sequenceAccession="NP_851830" sequenceVersion="1" change="p.Glu158fs">
            <Expression>NP_851830.1:p.Glu158fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_024048.3" sequenceAccession="NR_024048" sequenceVersion="3" change="n.926_929del">
            <Expression>NR_024048.3:n.926_929del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009634.2" sequenceAccession="NG_009634" sequenceVersion="2" change="g.13519_13522del">
            <Expression>NG_009634.2:g.13519_13522del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000116.5" sequenceAccession="NM_000116" sequenceVersion="5" change="c.605_608del" MANESelect="true">
            <Expression>NM_000116.5:c.605_608del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000107.1" sequenceAccession="NP_000107" sequenceVersion="1" change="p.Glu202fs">
            <Expression>NP_000107.1:p.Glu202fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001303465.2" sequenceAccession="NM_001303465" sequenceVersion="2" change="c.617_620del">
            <Expression>NM_001303465.2:c.617_620del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001290394.1" sequenceAccession="NP_001290394" sequenceVersion="1" change="p.Glu206fs">
            <Expression>NP_001290394.1:p.Glu206fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_131" sequenceAccession="LRG_131">
            <Expression>LRG_131:g.13519_13522del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_131t1" sequenceAccession="LRG_131t1">
            <Expression>LRG_131t1:c.605_608del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_131p1" sequenceAccession="LRG_131p1" change="p.Glu202fs">
            <Expression>LRG_131p1:p.Glu202fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="300394.0012" DB="OMIM" />
        <XRef Type="rs" ID="1603381671" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="ClinGen" Type="public">ClinGen staff contributed the HGVS expression for this variant.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000116.5(TAFAZZIN):c.605_608del (p.Glu202fs) AND 3-Methylglutaconic aciduria type 2" Accession="RCV000011860" Version="7">
        <ClassifiedConditionList TraitSetID="3071">
          <ClassifiedCondition DB="MedGen" ID="C0574083">3-Methylglutaconic aciduria type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2007-05-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2007-05-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2022-03-28">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17394203</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3071" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="487" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Barth syndrome</ElementValue>
                <XRef ID="MONDO:0010543" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">3-methylglutaconicaciduria type II</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MGA type II</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cardioskeletal myopathy with neutropenia and abnormal mitochondria</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">3-Methylglutaconic aciduria type 2</ElementValue>
                <XRef ID="Barth+Syndrome/744" DB="Genetic Alliance" />
                <XRef ID="297231002" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MGCA2</ElementValue>
                <XRef Type="MIM" ID="302060" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">BTHS</ElementValue>
                <XRef Type="MIM" ID="302060" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MGA2</ElementValue>
                <XRef Type="MIM" ID="302060" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5890" />
                <XRef ID="5890" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Barth syndrome is characterized in affected males by cardiomyopathy, neutropenia, skeletal myopathy, prepubertal growth delay, and distinctive facial gestalt (most evident in infancy); not all features may be present in a given affected male. Cardiomyopathy, which is almost always present before age five years, is typically dilated cardiomyopathy with or without endocardial fibroelastosis or left ventricular noncompaction; hypertrophic cardiomyopathy can also occur. Heart failure is a significant cause of morbidity and mortality; risk of arrhythmia and sudden death is increased. Neutropenia is most often associated with mouth ulcers, pneumonia, and sepsis. The nonprogressive myopathy predominantly affects the proximal muscles, and results in early motor delays. Prepubertal growth delay is followed by a postpubertal growth spurt with remarkable "catch-up" growth. Heterozygous females who have a normal karyotype are asymptomatic and have normal biochemical studies.</Attribute>
                <XRef ID="NBK247162" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301486</ID>
                <ID Source="BookShelf">NBK1309</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">25299040</ID>
                <ID Source="BookShelf">NBK247162</ID>
              </Citation>
              <XRef ID="111" DB="Orphanet" />
              <XRef ID="C0574083" DB="MedGen" />
              <XRef ID="MONDO:0010543" DB="MONDO" />
              <XRef Type="MIM" ID="302060" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="32093" SubmissionDate="2022-03-21" DateLastUpdated="2022-03-28" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300394.0012_BARTH SYNDROME" title="TAFAZZIN, 4-BP DEL, AGTG_BARTH SYNDROME" />
        <ClinVarAccession Accession="SCV000032093" DateUpdated="2022-03-28" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2007-05-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 12-year-old boy with Barth syndrome (BTHS; 302060), Marziliano et al. (2007) identified a 4-bp deletion in exon 8 of the TAZ gene inherited from his unaffected mother. The boy had left ventricular noncompaction and dilated cardiomyopathy, which was detected at 3 months, skeletal myopathy, recurrent oral aphthous ulcers, and cyclic neutropenia. Left ventricular function progressively improved since age 5 years and became subclinical and normal; he presented at age 11 with recurrent ulcers and signs of myopathy. A peripheral blood sample from the patient showed TAZ expression that was not significantly lower compared to controls, but myocardial TAZ expression in an endomyocardial biopsy performed on the proband at 6 months of age was significantly lower compared to age-matched controls. TAZ expression declined with age in controls as well, suggesting that tafazzin is essential during fetal and early postnatal life. The proband also carried a heterozygous mutation in the LDB3 gene (605906), which is associated with left ventricular noncompaction. The patient's father and brother also carried the LDB3 mutation and had evidence of left ventricular trabeculation without dysfunction. The significance of the LDB3 mutation was unclear.</Attribute>
              <Citation>
                <ID Source="PubMed">17394203</ID>
              </Citation>
              <XRef DB="OMIM" ID="302060" Type="MIM" />
              <XRef DB="OMIM" ID="605906" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TAFAZZIN" />
          </GeneList>
          <Name>TAFAZZIN, 4-BP DEL, AGTG</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP DEL, AGTG</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300394.0012" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">BARTH SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="32093" TraitType="Disease" MappingType="Name" MappingValue="BARTH SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C0574083" Name="3-Methylglutaconic aciduria type 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

